has completed its purchase of a group of microplate-reader and washer-product assets from Anthos Labtec Instruments, a unit of
Financial terms of the transaction weren't disclosed.
Harvard Bioscience, a developer of scientific instruments, said Wednesday that it expects the addition of the product lines to add roughly $2 million to $3 million in annualized revenue and to increase its earnings per share.
The company's stock was trading at $4.15, up 6 cents.
This story was created through a joint venture between TheStreet.com and IRIS.